Co-chromatography of a tamoxifen epoxide-deoxyguanylic acid adduct with a major DNA adduct formed in the livers of tamoxifen-treated rats

Tamoxifen is a potent liver carcinogen in rats and has been shown to form covalent DNA adducts in the livers of several species of rodent. We have shown previously by 32P-postlabelling (Carcinogenesis, 13, 2197–2203) that >85% of the total adducts detected and resolved by multi-directional TLC mi...

Full description

Saved in:
Bibliographic Details
Published in:Carcinogenesis (New York) 1994-05, Vol.15 (5), p.793-795
Main Authors: Phillips, David H., Hewer, Alan, White, Ian N. H., Farmer, Peter B.
Format: Article
Language:English
Subjects:
Animal tumors. Experimental tumors
Animals
Biological and medical sciences
Biotransformation
Chromatography, High Pressure Liquid - methods
Deoxyguanine Nucleotides - metabolism
DNA - analysis
DNA - drug effects
DNA - metabolism
Epoxy Compounds - metabolism
Experimental digestive system and abdominal tumors
Female
Liver - chemistry
Liver - metabolism
Medical sciences
Nucleotides - analysis
Nucleotides - metabolism
Rats
Rats, Inbred F344
Tamoxifen - analogs & derivatives
Tamoxifen - metabolism
Tamoxifen - pharmacokinetics
Tamoxifen - pharmacology
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tamoxifen is a potent liver carcinogen in rats and has been shown to form covalent DNA adducts in the livers of several species of rodent. We have shown previously by 32P-postlabelling (Carcinogenesis, 13, 2197–2203) that >85% of the total adducts detected and resolved by multi-directional TLC migrate as a single spot. In the present study, this material was further analysed by reverse-phase HPLC and resolved into two approximately equal components. Tamoxifen 1,2-epoxide, a postulated metabolite of tamoxifen, was reacted with DNA and polydeoxyribonucleotides and the products analysed. 32P-Postlabelling revealed three major adduct spots on TLC which comigrated with the three major adduct spots seen with DNA from livers of tamoxifen-treated rats. Moreover, the major epoxide adduct, which contained guanine as the modified base, eluted on HPLC as a single major peak coincident with one of the major peaks derived from the liver DNA of tamoxifen-treated rats. These results demonstrate that ˜40% of the tamoxifen-DNA adducts formed in vivo are chromatographically indistinguishable with the major product of the reaction of tamoxifen epoxide with guanine residues in DNA and provide important clues to the mechanism of activation of tamoxifen to a genotoxic carcinogen.
ISSN:0143-3334
1460-2180
DOI:10.1093/carcin/15.5.793